This content is machine translated Obesity Extent of weight reduction is prognostically relevant According to the World Health Organization (WHO), obesity is one of the greatest health risks. With increasing severity, the risk of various concomitant and secondary diseases increases. Obesity-related multimorbidity is...…
View Post 4 min This content is machine translated Case report: Drug-induced hepatitis Rare side effect of tirzepatide therapy The dual glucose-dependent insulinotropic polypeptide (GIP)/glucagon-like peptide 1 (GLP1) receptor agonist triazepatide has shown promise for improving glycemic control and weight loss. However, it can also have undesirable side effects....…
View Post 5 min This content is machine translated Obesity GLP-1-based drugs close the treatment gap The WHO has declared obesity to be a global health problem and weight reduction is an important measure in the prevention and treatment of metabolic diseases such as type 2…
View Post 5 min This content is machine translated Obesity GLP-1 analogs and dual incretin agonists to support weight loss. Pathological obesity is a key risk factor for the development of life-threatening secondary complications. Until recently, bariatric surgery was the only effective method for obesity sufferers to achieve a sustained…
View Post 3 min This content is machine translated GLP-1-RA in type 2 diabetes Broad spectrum of action – weight reduction is also supported GLP-1 receptor agonists promote insulin secretion from pancreatic beta cells, leading to decreased glucose release by the liver and increasing insulin sensitivity. Moreover, they slow down gastric emptying and thus…
View Post 2 min This content is machine translated Obesity Sustainable weight reduction with the help of new therapy options Eat less, move more – obese patients know these recommendations well. However, the implementation is anything but simple. And even if weight loss does occur, the dreaded rebound effect undoes…
View Post 6 min This content is machine translated Type 2 diabetes Better quality of life thanks to modern diabetes therapy The cardiovascular benefit of SGLT2 inhibitors and GLP1 analogues is now considered established, and non-diabetics may also benefit. For optimal results, therapy should be tailored to individual patient characteristics.
View Post 5 min This content is machine translated Obesity Weight reduction is required – is there a new patent remedy? Obesity is a risk factor for diabetes and other diseases. In addition to genetic predisposition, lifestyle factors also play a role. Weight reduction is central – is there a new…
View Post 2 min This content is machine translated Obesity and addiction “Food addiction” in overweight and obese adolescents. Purpose: The purpose of this study was to determine the prevalence and correlates of “food addiction” as measured by the Yale Food Addiction Scale (YFAS) in overweight and obese adolescents…
View Post 11 min This content is machine translated An impossibility? Weight reduction in patients with type 2 diabetes Increased body weight and diabetes mellitus often go hand in hand. Even if the topic of weight reduction in patients with diabetes is often difficult and difficult to implement, it…
View Post 5 min This content is machine translated Diabetes Highlights 2014 Weight reduction: the best diet is the one that the patient sticks to On December 11, 2014, diabetes experts from all over Switzerland provided information on current trends and news on diabetes mellitus at a one-day symposium. Outstanding studies published in 2014 were…
